TELA Bio, Inc. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
TELA Bio filed an 8-K on August 4, 2026 disclosing Item 5.02 regarding departures or appointments of officers and directors, and compensatory arrangements. The filing documents are present but specific names, dollar amounts, equity grants, vesting schedules, and effective dates are not provided in the accessible text—only metadata and filing structure are shown.
Why this rating
Unable to assess impact without disclosed specifics on who departed/was appointed and compensation terms. Standard officer/director disclosure; minimal context provided in available filing text.
Extracted items
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.